Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma

Clinical trial NCT01209871 · COMPLETED

Trial details

NCT number: NCT01209871
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoplasmacytic Lymphoma

Start date: 2015-02-26
Primary completion: 2025-04-22
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.